Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders

NCT06112639

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +26 more
Locations: IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli Brescia, Italy

IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy

IRCCS Fondazione Don Carlo Gnocchi ONLUS Milan, Italy

View Trial Details

Recruiting

Feasibility/Acceptability of Attentional-Control Training in Survivors

NCT05528939

Conditions: Attention Difficulties, Cognitive Deficit in Attention, Hematologic Diseases, +13 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

NCT06767254

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS Meldola, Forlì-Cesena, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

ARNAS "G. Brotzu" di Cagliari Cagliari, Italy

Azienda Ospedaliera Universitaria Federico II Naples, Italy

View Trial Details

Recruiting

Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management

NCT06764524

Conditions: Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)

NCT06759181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Xuzhou Xuzhou, China

View Trial Details

Recruiting

CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

NCT05054257

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +23 more
Locations: Institute of Hematology and Blood Transfusion, Czech Republic Prague, Czechia

View Trial Details

Recruiting

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

NCT06758713

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: The Third Affiliated Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

NCT06756321

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Affiliated Hospital of Nantong University Nantong, Jiangsu, China

View Trial Details

Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

NCT06734871

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Shanghai Tongji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)

NCT06755619

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Helsinki University Hospital Helsinki, Finland

Kuopio University Hospital Kuopio, Finland

Oulu University Hospital Oulu, Finland

Tampere University Hospital Tampere, Finland

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions